Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues:
Premiums		$ 1,108	$ 1,145	$ 3,029	$ 3,422
Net investment income		805	783	2,373	2,357
Net investment gains (losses)		20	(51)	31	(59)
Policy fees and other income		217	223	738	672
Total revenues		2,150	2,100	6,171	6,392
Benefits and expenses:
Benefits and other changes in policy reserves		1,662	1,290	3,715	3,714
Interest credited		173	179	523	540
Acquisition and operating expenses, net of deferrals		269	314	990	876
Amortization of deferred acquisition costs and intangibles		94	563	305	759
Interest expense		77	105	262	315
Total benefits and expenses		2,275	2,451	5,795	6,204
Income (loss) from continuing operations before income taxes		(125)	(351)	376	188
Provision (benefit) for income taxes		222	(134)	355	27
Income (loss) from continuing operations		(347)	(217)	21	161
Income (loss) from discontinued operations, net of taxes		15	(21)	(25)	(334)
Net loss		(332)	(238)	(4)	(173)
Less: net income attributable to noncontrolling interests		48	46	151	150
Net loss available to Genworth Financial, Inc.'s common stockholders		$ (380)	$ (284)	$ (155)	$ (323)
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		$ (0.79)	$ (0.53)	$ (0.26)	$ 0.02
Diluted		(0.79)	(0.53)	(0.26)	0.02
Net loss available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		(0.76)	(0.57)	(0.31)	(0.65)
Diluted		$ (0.76)	$ (0.57)	$ (0.31)	$ (0.65)
Weighted-average common shares outstanding:
Basic		498.3	497.4	498.3	497.3
Diluted	[1]	498.3	497.4	498.3	499.0
Supplemental disclosures:
Total other-than-temporary impairments		$ (2)	$ (10)	$ (35)	$ (13)
Portion of other-than-temporary impairments included in other comprehensive income (loss)		0	1	0	1
Net other-than-temporary impairments		(2)	(9)	(35)	(12)
Other investments gains (losses)		22	(42)	66	(47)
Net investment gains (losses)		$ 20	$ (51)	$ 31	$ (59)

[1] Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2016 and 2015 and the nine months ended September 30, 2016, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2016 and 2015 and the nine months ended September 30, 2016, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 2.2 million, 1.3 million and 1.8 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2016 and 2015 and the nine months ended September 30, 2016, dilutive potential weighted-average common shares outstanding would have been 500.5 million, 498.7 million and 500.1 million, respectively.